Pauline Arnaud1,2,3, Nadine Hanna1,2,3, Louise Benarroch2, Mélodie Aubart2, Laurence Bal4, Patrice Bouvagnet5, Tiffany Busa6, Yves Dulac7, Sophie Dupuis-Girod8, Thomas Edouard9, Laurence Faivre10, Laurent Gouya3, Didier Lacombe11,12, Maud Langeois3, Bruno Leheup13, Olivier Milleron3, Sophie Naudion11, Sylvie Odent14, Maria Tchitchinadze3, Jacques Ropers15, Guillaume Jondeau2,3, Catherine Boileau16,17,18. 1. Hôpital Bichat, Département de Génétique, Assistance Publique-Hôpitaux de Paris, Paris, France. 2. LVTS, INSERM U1148, Hôpital Bichat, Université Paris Diderot, Paris, France. 3. Hôpital Bichat, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Assistance Publique-Hôpitaux de Paris, Paris, France. 4. Hôpital Timone Adultes, Service de Chirurgie vasculaire, Assistance Publique-Hôpitaux de Marseille, Marseille, France. 5. Hospices Civils de Lyon, Hôpital Louis Pradel, Service de Cardiologie Pédiatrique et Congénitale adulte, Centre Hospitalier Universitaire de Lyon, Bron, France. 6. Hôpital Timone Enfants, Service de Génétique clinique, Département de Génétique Médicale, Assistance Publique-Hôpitaux de Marseille, Marseille, France. 7. Hôpital des Enfants, Service de Cardiologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. 8. Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de Génétique Clinique, Centre Hospitalier Universitaire de Lyon, Bron, France. 9. Hôpital des Enfants, Service de Pédiatrie - Endocrinologie, Génétique et Gynécologie Médicale, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. 10. Centre de Génétique et FHU TRANSLAD, Centre Hospitalier Universitaire Dijon, Dijon, France. 11. GH Pellegrin, Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. 12. INSERM U1211, Université de Bordeaux, Bordeaux, France. 13. Hôpital de Brabois, Service de Génétique Clinique, Centre Hospitalier Universitaire de Nancy, Vandœuvre-lès-, Nancy, France. 14. Hôpital Sud, Service de Génétique Clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France. 15. Unité de Recherche Clinique HU Paris Île-de-France Ouest, Boulogne, France. 16. Hôpital Bichat, Département de Génétique, Assistance Publique-Hôpitaux de Paris, Paris, France. catherine.boileau@inserm.fr. 17. LVTS, INSERM U1148, Hôpital Bichat, Université Paris Diderot, Paris, France. catherine.boileau@inserm.fr. 18. Hôpital Bichat, Centre de Référence Maladies Rares, Syndrome de Marfan et pathologies apparentées, Assistance Publique-Hôpitaux de Paris, Paris, France. catherine.boileau@inserm.fr.
Abstract
PURPOSE: Heritable thoracic aortic aneurysms and dissections (hTAAD) are life-threatening complications of well-known syndromic diseases or underdiagnosed nonsyndromic heritable forms (nshTAAD). Both have an autosomal dominant transmission and are genetically heterogeneous. Our objective was to describe the relevance of molecular diagnosis in these patients and the contribution of each gene in nshTAAD. METHODS: Two hundred twenty-six consecutive nshTAAD probands, either young (<45 years) sporadic or familial cases were included. A next-generation sequencing capture panel comprising 23 known disease-causing genes was performed. RESULTS: Class 4 or 5 variants were identified in 18% of the nshTAAD probands, while class 3 variants were found in 10% of them. The yield in familial cases was greater than in sporadic cases. SMAD3 and FBN1 genes were the major disease-causing genes. Unexpectedly, no premature termination codon variant was identified in the FBN1 gene. Furthermore, we report for the first time that aortic dissection or surgery occurred significantly more often and earlier in probands with a class 4 or 5 pathogenic variant. CONCLUSION: This study indicates that genetic screening using NGS is efficient in young and familial nshTAAD. The presence of a pathogenic variant has a possible predictive value, which needs to be further investigated because it may influence care.
PURPOSE: Heritable thoracic aortic aneurysms and dissections (hTAAD) are life-threatening complications of well-known syndromic diseases or underdiagnosed nonsyndromic heritable forms (nshTAAD). Both have an autosomal dominant transmission and are genetically heterogeneous. Our objective was to describe the relevance of molecular diagnosis in these patients and the contribution of each gene in nshTAAD. METHODS: Two hundred twenty-six consecutive nshTAAD probands, either young (<45 years) sporadic or familial cases were included. A next-generation sequencing capture panel comprising 23 known disease-causing genes was performed. RESULTS: Class 4 or 5 variants were identified in 18% of the nshTAAD probands, while class 3 variants were found in 10% of them. The yield in familial cases was greater than in sporadic cases. SMAD3 and FBN1 genes were the major disease-causing genes. Unexpectedly, no premature termination codon variant was identified in the FBN1 gene. Furthermore, we report for the first time that aortic dissection or surgery occurred significantly more often and earlier in probands with a class 4 or 5 pathogenic variant. CONCLUSION: This study indicates that genetic screening using NGS is efficient in young and familial nshTAAD. The presence of a pathogenic variant has a possible predictive value, which needs to be further investigated because it may influence care.
Entities:
Keywords:
FBN1 gene; NGS; SMAD3 gene; class 4 and 5 variants; thoracic aortic aneurysms and dissections
Authors: Changjiang Yu; Ying Li; Abuduresuli Adilijang; Jizhong Yan; Arkin Guzalnur; Abudula Abudushalamu; Yimamu Aimirela; Ruixin Fan Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2020-11-30
Authors: Alana C Cecchi; Maura L Boerio; Isabella Marin; Amélie Pinard; Dianna M Milewicz Journal: J Am Heart Assoc Date: 2022-04-06 Impact factor: 6.106
Authors: Alexander J Fletcher; Maaz B J Syed; Timothy J Aitman; David E Newby; Niki L Walker Journal: Circulation Date: 2020-05-11 Impact factor: 29.690
Authors: Philipp Erhart; Daniel Körfer; Caspar Grond-Ginsbach; Jia-Lu Qiao; Moritz S Bischoff; Maja Hempel; Christian P Schaaf; Armin Grau; Dittmar Böckler Journal: J Cardiovasc Dev Dis Date: 2022-01-05
Authors: Laurence Campens; Lucia Baris; Nandita S Scott; Craig S Broberg; Antione Bondue; Guillaume Jondeau; Jasmine Grewal; Mark R Johnson; Roger Hall; Julie De Backer; Jolien W Roos-Hesselink Journal: Heart Date: 2021-01-19 Impact factor: 5.994